Coronavirus Disease 2019 Clinical Trial
Official title:
Effects of Awake Prone Positioning on Oxygenation and Physiological Outcomes in Non-intubated COVID-19 Patients
Verified date | January 2022 |
Source | Damanhour University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The burden of coronavirus disease 2019 (COVID-19) pandemic is still on a rising course making a great stress on medical resources throughout the world. Although most of COVID-19 patients require non-invasive oxygenation and ventilation, rapid progression to hypoxemic respiratory failure and then acute respiratory distress syndrome (ARDS) can occur in some COVID19 patients due to prolonged or unaddressed hypoxia. Prone positioning is a common supportive ventilation strategy to improve oxygenation in critically ill patients with ARDS. Recent studies point out the potential benefits of using this strategy for non-intubated awake COVID 19 patients who are hypoxic. Despite several retrospective cohort studies have been conducted to identify impact of the prone positioning in awake non-intubated COVID-19 patients, experimental studies are very rare. This study therefore aims to evaluate the effects of self-prone positioning on oxygenation and physiological outcomes among awake-non intubated patients with COVID-19.
Status | Completed |
Enrollment | 82 |
Est. completion date | April 20, 2021 |
Est. primary completion date | March 20, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: 1. Aged 18-75 years old 2. Awake non-intubated spontaneously breathing patients 3. Confirmed diagnosis of severe COVID-19; manifesting as dyspnea with respiratory rate = 30 breaths/min, pulse rate = 100 beats/min, oxygen saturation =93%, or partial pressure of arterial oxygen (PaO2) to fraction of inspired oxygen (FiO2) ratio = 150 mmHg. 4. Positive RT-PCR for SARS-CoV-2 from analysis of nasopharyngeal, oropharyngeal swab, or tracheal secretion specimens and with chest X-ray showing bilateral infiltrations or chest computerized tomographic (CT) images showing exudation or consolidation. 5. Requiring supplemental oxygen (nasal cannula, non-invasive CPAP, non-rebreathing face mask) 6. Capable of adopting a prone posture independently. Exclusion Criteria: The presence of any of the following will mean patients are ineligible: 1. life-threatening arrhythmias 2. Hemodynamic instability (defined as mean arterial pressure [MAP] < 65mm Hg and use of vasopressors to achieve MAP > 65 mm Hg) 3. Altered mental status, intracranial hypertension 4. Facial injuries 5. Spine or pelvic fractures 6. Recent abdominal surgery 7. Pregnancy 8. Altered mental status and patients needing invasive ventilation. |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of nursing | Alexandria |
Lead Sponsor | Collaborator |
---|---|
Damanhour University |
Egypt,
Binda F, Marelli F, Galazzi A, Pascuzzo R, Adamini I, Laquintana D. Nursing Management of Prone Positioning in Patients With COVID-19. Crit Care Nurse. 2021 Apr 1;41(2):27-35. doi: 10.4037/ccn2020222. — View Citation
Cotton S, Zawaydeh Q, LeBlanc S, Husain A, Malhotra A. Proning during covid-19: Challenges and solutions. Heart Lung. 2020 Nov - Dec;49(6):686-687. doi: 10.1016/j.hrtlng.2020.08.006. Epub 2020 Aug 19. — View Citation
Dubosh NM, Wong ML, Grossestreuer AV, Loo YK, Sanchez LD, Chiu D, Leventhal EL, Ilg A, Donnino MW. Early, awake proning in emergency department patients with COVID-19. Am J Emerg Med. 2021 Aug;46:640-645. doi: 10.1016/j.ajem.2020.11.074. Epub 2020 Dec 3. — View Citation
Flynn Makic MB. Prone Position of Patients With COVID-19 and Acute Respiratory Distress Syndrome. J Perianesth Nurs. 2020 Aug;35(4):437-438. doi: 10.1016/j.jopan.2020.05.008. Epub 2020 May 30. — View Citation
Solverson K, Weatherald J, Parhar KKS. Tolerability and safety of awake prone positioning COVID-19 patients with severe hypoxemic respiratory failure. Can J Anaesth. 2021 Jan;68(1):64-70. doi: 10.1007/s12630-020-01787-1. Epub 2020 Aug 14. — View Citation
Sztajnbok J, Maselli-Schoueri JH, Cunha de Resende Brasil LM, Farias de Sousa L, Cordeiro CM, Sansão Borges LM, Malaque CMSA. Prone positioning to improve oxygenation and relieve respiratory symptoms in awake, spontaneously breathing non-intubated patients with COVID-19 pneumonia. Respir Med Case Rep. 2020;30:101096. doi: 10.1016/j.rmcr.2020.101096. Epub 2020 May 19. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Oxygenation index | arterial oxygen pressure/fractional inspired oxygen PaO2/FiO2 ratio mmHg. | Change in the value immediately before, after 10 minutes and after 1hour of patient positioning | |
Primary | SpO2 | Peripheral oxygen saturation | Change in the value immediately before, after 10 minutes and after 1hour of patient positioning. | |
Primary | ROX index | combination of the ratio of oxygen saturation measured by pulse oximetry to fraction of inspired ox¬ygen and respiratory rate ([SpO2/FiO2]/respiratory rate) | Change in the value immediately before and after 1hour of patient positioning. | |
Primary | PaO2mmHg | Partial pressure of oxygen within arterial blood | change in the value immediately before and after 1hour of patient positioning. | |
Primary | PCO2mmHg | The partial pressure of carbon dioxide within arterial blood | change in the value immediately before and after 1hour of patient positioning. | |
Primary | SaO2 | Oxygen saturation (SaO2) is a measurement of the percentage of how much hemoglobin is saturated with oxygen. | change in the value immediately before and after 1hour of patient positioning. | |
Primary | pH | The acidity or alkalinity of blood. | change in the value immediately before and after 1hour of patient positioning. | |
Primary | Respiratory Rate (RR) (bpm) | the number of breaths a person takes per minute. | change in the value immediately before, after 10 minutes and after 1hour of patient positioning. | |
Primary | Heart Rate (HR) (bpm) | is the the speed of the heartbeat measured by the number of contractions (beats) of the heart per minute (bpm) | change in the value immediately before, after 10 minutes and after 1hour of patient positioning. | |
Primary | Blood Pressure (BP) mmHg | is the the pressure of circulating blood against the walls of blood vessels. | change in the value immediately before, after 10 minutes and after 1hour of patient positioning. | |
Primary | Positive response to prone positioning | defined as a 10% increase in PaO2/FiO2 ratio or 10% decrease in respiratory rate | Time Frame: change in the value of PaO2/FiO2 ratio or respiratory rate after 1hour of patient positioning | |
Secondary | Prone position adverse events | respiratory distress, dyspnea, use of accessory respiratory muscles, oxygen desaturation SpO2=70%, hypotension SBP=90 mmHg, vomiting, aspiration, musculoskeletal pain, discomfort, facial edema, pressure ulcers and accidental withdrawal of catheters, tubes and/or drainages. | appearance of events from 10 minutes after patient positioning up to 3hours after patient positioning.. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05091411 -
Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)
|
Phase 3 | |
Completed |
NCT05107375 -
Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine
|
Phase 3 | |
Active, not recruiting |
NCT05128643 -
Clinical Study on the Immune Program of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell)
|
Phase 3 | |
Completed |
NCT04988217 -
Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)
|
Phase 1/Phase 2 | |
Completed |
NCT04579393 -
Fostamatinib for Hospitalized Adults With COVID-19
|
Phase 2 | |
Withdrawn |
NCT04390217 -
LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia
|
Phase 2 | |
Recruiting |
NCT05047783 -
Masitinib in Patients With Symptomatic Mild to Moderate COVID-19
|
Phase 2 | |
Completed |
NCT04646044 -
A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19
|
Phase 1 | |
Not yet recruiting |
NCT06392451 -
LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia
|
N/A | |
Recruiting |
NCT05092568 -
Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service
|
||
Completed |
NCT05364268 -
Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation
|
||
Completed |
NCT06189040 -
Immunogenicity After COVID-19 Vaccines in Adapted Schedules
|
Phase 4 | |
Recruiting |
NCT04401436 -
COVID-19 Associated Lymphopenia Pathogenesis Study in Blood
|
||
Not yet recruiting |
NCT04395742 -
1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study
|
||
Recruiting |
NCT04388631 -
Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.
|
||
Completed |
NCT05501288 -
Huashi Baidu Granule in the Treatment of Pediatric Patients With Mild Coronavirus Disease 2019
|
N/A | |
Active, not recruiting |
NCT05216471 -
Identify Coronavirus Disease by Chest X-ray
|
||
Terminated |
NCT04672564 -
Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients
|
Phase 3 | |
Completed |
NCT04967781 -
Autoimmunity Contributes to the Severe Progression of COVID-19
|
||
Completed |
NCT04678830 -
Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19
|
Phase 2 |